Tapewire

OTC · USD

PTIX

Protagenic Therapeutics, Inc.\new

Export transactions ↓
Tapewire entity
8496
SEC CIK
0001022899
Parsed reports
40

Last 12 months

Inside the activity.

7 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202610
Aug 202660
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 21, 2026 Filed Aug 24, 2026 17:20 UTC
ARMEN GARO HDirector · EXEC. CHAIR & PRINCIPAL OFF
PurchaseCOMMON STOCK 20,000 $0.65 $13,000.00
Disclosure

SEC source: 0001493152-26-039816 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · EXEC. CHAIR & PRINCIPAL OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,533

Read SEC document
August 20, 2026 Filed Aug 21, 2026 00:20 UTC
ARMEN GARO HDirector · EXEC. CHAIR & PRINCIPAL OFF
PurchaseCOMMON STOCK 16,634 $0.59 $9,810.73
Disclosure

SEC source: 0001493152-26-039537 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · EXEC. CHAIR & PRINCIPAL OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,533

Read SEC document
August 19, 2026 Filed Aug 20, 2026 13:23 UTC
ARMEN GARO HDirector · EXEC. CHAIR & PRINCIPAL OFF
PurchaseCOMMON STOCK 2,700 $0.35 $945.00
Disclosure

SEC source: 0001493152-26-039399 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · EXEC. CHAIR & PRINCIPAL OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,899

Read SEC document
August 11, 2026 Filed Aug 12, 2026 22:51 UTC
ARMEN GARO HDirector · EXEC. CHAIR & PRINCIPAL OFF
PurchaseCOMMON STOCK 2,220 $0.32 $710.40
Disclosure

SEC source: 0001493152-26-037468 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · EXEC. CHAIR & PRINCIPAL OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,199

Read SEC document
August 06, 2026 Filed Aug 10, 2026 14:17 UTC
ARMEN GARO HDirector · EXEC. CHAIR & PRINCIPAL OFF
PurchaseCOMMON STOCK 685 $0.22 $150.70
Disclosure

SEC source: 0001493152-26-036782 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · EXEC. CHAIR & PRINCIPAL OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,979

Read SEC document
August 05, 2026 Filed Aug 7, 2026 00:29 UTC
ARMEN GARO HDirector · EXEC. CHAIR & PRINCIPAL OFF
PurchaseCOMMON STOCK 5,000 $0.26 $1,294.00
Disclosure

SEC source: 0001493152-26-036442 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · EXEC. CHAIR & PRINCIPAL OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,294

Read SEC document
July 30, 2026 Filed Aug 3, 2026 21:29 UTC
ARMEN GARO HDirector · EXEC. CHAIR & PRINCIPAL OFF.
PurchaseCOMMON STOCK 26,291 $0.18 $4,805.99
Disclosure

SEC source: 0001493152-26-035868 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · EXEC. CHAIR & PRINCIPAL OFF.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,291

Read SEC document
March 25, 2024 Filed Mar 30, 2024 01:29 UTC
ARMEN GARO HDirector · Executive Chairman · 10% owner
GrantPTIX Common stock Options · Derivative 250,000 $1.74 Strike: $1.74 $435,000.00
Disclosure

SEC source: 0001493152-24-012068 · ownership.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 250,000 shares

Expires 2034-03-25

Read SEC document
March 25, 2024 Filed Mar 30, 2024 01:29 UTC GrantPTIX Common stock Options · Derivative 75,000 $1.74 Strike: $1.74 $130,500.00
Disclosure

SEC source: 0001493152-24-012073 · ownership.xml · derivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 75,000 shares

Expires 2034-03-25

F1 · derivative.exercise_date: 50,000 of the options are fully-exerciseable on March 25, 2026. The other 25,000 of the options are exercisable on and after the date upon which the company consummates a corporate partnership, if that occurs before December 31, 2026. If the company does not enter into a corporate partnership before December 31, 2026, then those 25,000 options are never exercisable.

Read SEC document
March 25, 2024 Filed Mar 30, 2024 01:29 UTC GrantPTIX Common stock Options · Derivative 75,000 $1.74 Strike: $1.74 $130,500.00
Disclosure

SEC source: 0001493152-24-012071 · ownership.xml · derivative · entry 1

Buell Jennifer · CIK 0001711184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 75,000 shares

Expires 2034-03-25

F1 · derivative.exercise_date: 50,000 of the options are fully-exerciseable on March 25, 2026. The other 25,000 of the options are exercisable on and after the date upon which the company consummates a corporate partnership, if that occurs before December 31, 2026. If the company does not enter into a corporate partnership before December 31, 2026, then those 25,000 options are never exercisable.

Read SEC document
March 25, 2024 Filed Mar 30, 2024 01:29 UTC GrantPTIX Common stock Options · Derivative 22,500 $1.74 Strike: $1.74 $39,150.00
Disclosure

SEC source: 0001493152-24-012070 · ownership.xml · derivative · entry 1

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

Underlying: PTIX common stock, Par Value $0.0001 · 22,500 shares

Expires 2034-03-25

Read SEC document
March 25, 2024 Filed Mar 30, 2024 01:29 UTC GrantPTIX Common stock Options · Derivative 43,750 $1.74 Strike: $1.74 $76,125.00
Disclosure

SEC source: 0001493152-24-012072 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,750

Underlying: PTIX Common Stock, Par Value $0.0001 · 43,750 shares

Expires 2034-03-25

Read SEC document
March 25, 2024 Filed Mar 30, 2024 01:29 UTC
Arrow Alexander K.Chief Financial Officer
GrantPTIX Common stock Options · Derivative 100,000 $1.74 Strike: $1.74 $174,000.00
Disclosure

SEC source: 0001493152-24-012069 · ownership.xml · derivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 100,000 shares

Expires 2034-03-25

Read SEC document
March 25, 2024 Filed Apr 2, 2024 01:41 UTC GrantPTIX Common stock Options · Derivative 21,250 $1.74 Strike: $1.74 $36,975.00
Disclosure

SEC source: 0001493152-24-012598 · ownership.xml · derivative · entry 1

WRIGHT TIMOTHY R · CIK 0001288245 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,250

Underlying: PTIX Common Stock, Par Value $0.0001 · 21,250 shares

Expires 2034-03-25

Read SEC document
October 12, 2023 Filed Oct 13, 2023 16:48 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIX Common Stock 8,000 $0.81 $6,480.00
Disclosure

SEC source: 0001493152-23-037136 · ownership.xml · nonDerivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,815

Read SEC document
May 18, 2022 Filed May 18, 2022 21:11 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIX Common Stock 8,000 $0.72 $5,760.00
Disclosure

SEC source: 0001493152-22-014338 · ownership.xml · nonDerivative · entry 2

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,260

Read SEC document
May 17, 2022 Filed May 18, 2022 21:11 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIX Common Stock 23,000 $0.71 $16,330.00
Disclosure

SEC source: 0001493152-22-014338 · ownership.xml · nonDerivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,260

Read SEC document
June 03, 2021 Filed Jun 3, 2021 22:13 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIXW Common Stock 5-year warrants strike price $4.98 · Derivative 16,900 $0.38 Strike: $4.98 $6,422.00
Disclosure

SEC source: 0001493152-21-013554 · ownership.xml · derivative · entry 2

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: PTIX Common Stock · 16,900 shares

Expires 2026-04-26

Read SEC document
June 02, 2021 Filed Jun 3, 2021 22:13 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIXW Common Stock 5-year warrants strike price $4.98 · Derivative 100 $0.38 Strike: $4.98 $38.00
Disclosure

SEC source: 0001493152-21-013554 · ownership.xml · derivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,100

Underlying: PTIX Common Stock · 100 shares

Expires 2026-04-26

Read SEC document
May 27, 2021 Filed Jun 1, 2021 10:05 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIXW Common Stock 5-year warrants strike price $4.98 · Derivative 3,000 $0.38 Strike: $4.98 $1,140.00
Disclosure

SEC source: 0001493152-21-013279 · ownership.xml · derivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

Underlying: PTIX Common Stock · 3,000 shares

Expires 2026-04-26

Read SEC document
May 26, 2021 Filed Jun 1, 2021 22:54 UTC GrantPTIX Common stock NSO Options · Derivative 180,000 $0.00 Strike: $3.65 $0.00
Disclosure

SEC source: 0001493152-21-013384 · ownership.xml · derivative · entry 1

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: PTIX common stock, Par Value $0.000001 · 180,000 shares

Expires 2031-05-26

F1 · derivative.exercise_price: This exercise price was determined by the Board of Directors at a Board Meeting held May 26, 2021.

F2 · shares: This number of options was determined by the Board of Directors at a Board Meeting held May 26, 2021.

F3 · derivative.exercise_date: The options are fully vested.

F2 · derivative.underlying_shares: This number of options was determined by the Board of Directors at a Board Meeting held May 26, 2021.

Read SEC document
May 18, 2021 Filed May 20, 2021 20:24 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIXW Common Stock 5-year warrants strike price $4.98 · Derivative 18,000 $0.31 Strike: $4.98 $5,580.00
Disclosure

SEC source: 0001493152-21-012357 · ownership.xml · derivative · entry 2

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: PTIX Common Stock · 18,000 shares

Expires 2026-04-26

Read SEC document
May 18, 2021 Filed May 20, 2021 20:24 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIXW Common Stock 5-year warrants strike price $4.98 · Derivative 12,000 $0.32 Strike: $4.98 $3,840.00
Disclosure

SEC source: 0001493152-21-012357 · ownership.xml · derivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: PTIX Common Stock · 12,000 shares

Expires 2026-04-26

Read SEC document
May 03, 2021 Filed May 5, 2021 10:10 UTC Exercise / conversionPTIX Common stock Options · Derivative 120,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001493152-21-010465 · ownership.xml · derivative · entry 8

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: PTIX common stock, Par Value $0.000001 · 120,000 shares

Expires 2030-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction.

F3 · derivative.exercise_date: The options are fully vested.

Read SEC document
May 03, 2021 Filed May 5, 2021 10:10 UTC Exercise / conversionPTIX Common stock Options · Derivative 45,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001493152-21-010465 · ownership.xml · derivative · entry 7

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: PTIX common stock, Par Value $0.000001 · 45,000 shares

Expires 2027-10-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction.

F3 · derivative.exercise_date: The options are fully vested.

Read SEC document
May 03, 2021 Filed May 5, 2021 10:10 UTC Exercise / conversionPTIX Common stock Options · Derivative 150,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001493152-21-010465 · ownership.xml · derivative · entry 6

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,000

Underlying: PTIX common stock, Par Value $0.000001 · 150,000 shares

Expires 2027-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction.

F3 · derivative.exercise_date: The options are fully vested.

Read SEC document
May 03, 2021 Filed May 5, 2021 10:10 UTC Exercise / conversionPTIX Common stock Options · Derivative 45,000 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001493152-21-010465 · ownership.xml · derivative · entry 5

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,000

Underlying: PTIX common stock, Par Value $0.000001 · 45,000 shares

Expires 2026-04-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction.

F3 · derivative.exercise_date: The options are fully vested.

Read SEC document
May 03, 2021 Filed May 5, 2021 10:10 UTC Exercise / conversionProtagenic Therapeutics, Inc. Common Stock 120,000 $1.75 $210,000.00
Disclosure

SEC source: 0001493152-21-010465 · ownership.xml · nonDerivative · entry 4

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 410,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: $532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise.

Read SEC document
May 03, 2021 Filed May 5, 2021 10:10 UTC Exercise / conversionProtagenic Therapeutics, Inc. Common Stock 45,000 $1.75 $78,750.00
Disclosure

SEC source: 0001493152-21-010465 · ownership.xml · nonDerivative · entry 3

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: $532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise.

Read SEC document
May 03, 2021 Filed May 5, 2021 10:10 UTC Exercise / conversionProtagenic Therapeutics, Inc. Common Stock 150,000 $1.25 $187,500.00
Disclosure

SEC source: 0001493152-21-010465 · ownership.xml · nonDerivative · entry 2

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: $532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise.

Read SEC document
May 03, 2021 Filed May 5, 2021 10:10 UTC Exercise / conversionProtagenic Therapeutics, Inc. Common Stock 45,000 $1.25 $56,250.00
Disclosure

SEC source: 0001493152-21-010465 · ownership.xml · nonDerivative · entry 1

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: $532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise.

Read SEC document
April 30, 2021 Filed May 3, 2021 20:15 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIX Common Stock 1,000 $2.29 $2,290.00
Disclosure

SEC source: 0001493152-21-010335 · ownership.xml · nonDerivative · entry 2

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,260

Read SEC document
April 29, 2021 Filed May 3, 2021 20:15 UTC
Arrow Alexander K.Chief Financial Officer
PurchasePTIX Common Stock 1,000 $2.29 $2,290.00
Disclosure

SEC source: 0001493152-21-010335 · ownership.xml · nonDerivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,260

Read SEC document
July 18, 2020 Filed Jul 21, 2020 21:05 UTC
Arrow Alexander K.Chief Financial Officer
GrantPTIX Common stock Options · Derivative 124,998 $1.75 Strike: $1.75 $218,746.50
Disclosure

SEC source: 0001493152-20-013712 · ownership.xml · derivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,998

Underlying: PTIX Common Stock, Par Value $0.0001 · 124,998 shares

Expires 2030-07-18

Read SEC document
July 18, 2020 Filed Jul 21, 2020 21:06 UTC GrantPTIX Common stock Options · Derivative 145,000 $1.75 Strike: $1.75 $253,750.00
Disclosure

SEC source: 0001493152-20-013713 · ownership.xml · derivative · entry 1

Buell Jennifer · CIK 0001711184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 145,000 shares

Expires 2030-07-18

Read SEC document
February 21, 2020 Filed Feb 27, 2020 01:21 UTC
ARMEN GARO HDirector · Executive Chairman · 10% owner
GrantPTIX Common stock Options · Derivative 300,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001493152-20-003037 · ownership.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 300,000 shares

Expires 2030-02-21

Read SEC document
February 21, 2020 Filed Feb 27, 2020 01:32 UTC GrantPTIX Common stock Options · Derivative 150,000 Not disclosed Strike: $1.75 Not disclosed
Disclosure

SEC source: 0001493152-20-003043 · ownership.xml · derivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 150,000 shares

Expires 2030-02-21

F1 · price: As this was an option grant, there was no cost to the recipient.

Read SEC document
February 21, 2020 Filed Feb 27, 2020 01:26 UTC GrantPTIX Common stock Options · Derivative 120,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001493152-20-003039 · ownership.xml · derivative · entry 1

Silverman Joshua · CIK 0001524858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 120,000 shares

Expires 2030-02-21

Read SEC document
February 21, 2020 Filed Feb 27, 2020 01:29 UTC GrantPTIX Common stock Options · Derivative 120,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001493152-20-003041 · ownership.xml · derivative · entry 1

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: PTIX common stock, Par Value $0.0001 · 120,000 shares

Expires 2030-02-21

Read SEC document
February 21, 2020 Filed Feb 27, 2020 01:15 UTC
Arrow Alexander K.Chief Financial Officer
GrantPTIX Common stock Options · Derivative 307,497 Not disclosed Strike: $1.75 Not disclosed
Disclosure

SEC source: 0001493152-20-003033 · ownership.xml · derivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,497

Underlying: PTIX Common Stock, Par Value $0.0001 · 307,497 shares

Expires 2030-02-21

F1 · price: As this was an option grant, there was no cost to the recipient.

Read SEC document
February 21, 2020 Filed Feb 27, 2020 01:18 UTC GrantPTIX Common stock Options · Derivative 120,000 Not disclosed Strike: $1.75 Not disclosed
Disclosure

SEC source: 0001493152-20-003035 · ownership.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: PTIX Common Stock, Par Value $0.0001 · 120,000 shares

Expires 2030-02-21

F1 · price: As this was an option grant, there was no cost to the recipient.

Read SEC document
November 20, 2019 Filed Feb 24, 2020 19:12 UTC
ARMEN GARO HDirector · Executive Chairman · 10% owner
PurchaseConvertible Note · Derivative Not disclosed $200,000.00 Strike: $1.25 $200,000.00
Disclosure

SEC source: 0001493152-20-002879 · ownership.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common stock, par value $0.0001 per share · 160,000 shares

Expires 2023-11-06

F1 · security: The reported transaction is the purchase of a convertible note, convertible at the holder's discretion at any time into common stock at the rate of $1.25 per share.

Read SEC document
November 05, 2019 Filed Feb 24, 2020 19:16 UTC PurchaseConvertible Note · Derivative Not disclosed $50,000.00 Strike: $1.25 $50,000.00
Disclosure

SEC source: 0001493152-20-002881 · ownership.xml · derivative · entry 1

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common stock, par value $0.0001 per share · 40,000 shares

Expires 2023-11-06

F1 · security: The reported transaction is the purchase of a convertible note, convertible at the holder's discretion at any time into common stock at the rate of $1.25 per share.

Read SEC document
March 20, 2019 Filed Mar 25, 2019 10:10 UTC
Arrow Alexander K.Chief Financial Officer
GrantPTIX Common stock Options · Derivative 41,667 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001493152-19-003805 · ownership.xml · derivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Underlying: PTIX · 41,667 shares

Expires 2029-03-20

Read SEC document
October 16, 2017 Filed Oct 18, 2017 18:42 UTC
ARMEN GARO HDirector · Executive Chairman · 10% owner
GrantNon-Qualified Stock Options (Right to Buy) · Derivative 250,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001437749-17-017237 · rdgdoc.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Protagenic Therapeutics, Inc. Common Stock · 250,000 shares

Expires 2027-10-16

F1 · derivative.exercise_date: Vesting in equal installments over 36 months, full vesting upon change of control

Read SEC document
October 16, 2017 Filed Oct 18, 2017 21:34 UTC GrantNon-Qualified Stock Options (Right to Buy) · Derivative 95,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001437749-17-017263 · rdgdoc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Protagenic Therapeutics, Inc. Common Stock · 95,000 shares

Expires 2027-10-16

F1 · derivative.exercise_date: Vesting in equal installments over 18 months

Read SEC document
October 16, 2017 Filed Oct 18, 2017 18:46 UTC
Arrow Alexander K.Chief Financial Officer
GrantNon-Qualified Stock Options (Right to Buy) · Derivative 75,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001437749-17-017238 · rdgdoc.xml · derivative · entry 1

Arrow Alexander K. · CIK 0001497166 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Protagenic Therapeutics, Inc. Common Stock · 75,000 shares

Expires 2027-10-16

F1 · derivative.exercise_date: Vesting in equal installments over 36 months, full vesting upon change of control

Read SEC document
October 16, 2017 Filed Oct 18, 2017 18:23 UTC GrantNon-Qualified Stock Options (Right to Buy() · Derivative 200,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001437749-17-017235 · rdgdoc.xml · derivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Protagenic Therapeutics, Inc. Common Stock · 200,000 shares

Expires 2027-10-16

F1 · derivative.exercise_date: Vesting in equal installments over 18 months

Read SEC document
October 16, 2017 Filed Oct 18, 2017 18:13 UTC GrantNon-Qualified Stock Options (Right to Buy) · Derivative 45,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001437749-17-017233 · rdgdoc.xml · derivative · entry 1

Barrage Khalil · CIK 0001666011 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Protagenic Therapeutics, Inc. Common Stock · 45,000 shares

Expires 2027-10-16

F1 · derivative.exercise_date: Vesting in equal installments over 18 months

Read SEC document
October 16, 2017 Filed Oct 18, 2017 18:18 UTC GrantNon-Qualified Stock Options (Right to Buy) · Derivative 45,000 $0.00 Strike: $1.75 $0.00
Disclosure

SEC source: 0001437749-17-017234 · rdgdoc.xml · derivative · entry 1

Silverman Joshua · CIK 0001524858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Protagenic Therapeutics, Inc. Common Stock · 45,000 shares

Expires 2027-10-16

F1 · derivative.exercise_date: Vesting in equal installments over 18 months

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.